Skip to main content
COSMAX, INC. logo

COSMAX, INC. — Investor Relations & Filings

Ticker · 192820 ISIN · KR7192820009 LEI · 988400ZU10J4AP3M4Y14 KO Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2019-09-24 Regulatory Filings
Country KR South Korea
Listing KO 192820

About COSMAX, INC.

https://www.cosmax.com/

COSMAX, INC. is a global research, development, and manufacturing company specializing in cosmetics and health functional foods. As a leading Original Design Manufacturer (ODM), it provides comprehensive, science-backed services across the entire product pipeline, from formulation and ingredient development to full-scale production. The company supports a diverse portfolio of hundreds of global brands, leveraging a network of advanced research and production facilities. With a significant focus on innovation, its large research team develops a wide range of products, including skincare, makeup, and dietary supplements, for its international clientele.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(특허권취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cosmax regarding the acquisition of a patent ('특허권 취득'). It follows the standard format for 'Major Management Matters' (주요경영사항) filings in the Korean market, which are used to disclose material events to investors. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory announcement category.
2019-09-24 Korean
채무인수결정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory announcement regarding a 'Debt Assumption Decision' (채무인수결정) by Cosmax. It details the amount, the relationship with the debtor, and the board resolution date. Since this relates to financing activities and capital structure changes (debt assumption), it falls under the 'Capital/Financing Update' category.
2019-09-18 Korean
단기차입금증가결정
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from Cosmax regarding a decision to increase short-term borrowings. It details the amount, purpose (real estate acquisition), and board approval date. This falls under financing activities and capital structure changes, which aligns with the 'CAP' (Capital/Financing Update) category.
2019-09-18 Korean
투자판단관련주요경영사항(실용신안권취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cosmax regarding the acquisition of a utility model right (patent-related intellectual property). It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean market, which is a general regulatory disclosure. Since it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2019-09-17 Korean
투자판단관련주요경영사항(특허권취득)
Regulatory Filings Classification · 1% confidence The document is a formal regulatory disclosure from Cosmax regarding the acquisition of a patent. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) required by Korean financial regulators (KRX). Since it does not fit into specific categories like M&A, dividends, or board changes, and is a standard regulatory disclosure of a material event, it falls under the RNS (Regulatory Filings) category.
2019-09-17 Korean
투자판단관련주요경영사항(특허권취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cosmax regarding the acquisition of a patent. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean market, which is a disclosure of a specific corporate event. Since it does not fit into specific categories like M&A, dividends, or share buybacks, it falls under the general regulatory filing category.
2019-09-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.